Postpartum patients who develop or carry chronic Q fever face a distinct clinical course. When elevated antibody titers persist for more than 12 months after delivery, a targeted, prolonged treatment protocol is required — one that differs meaningfully from standard acute Q fever management.
This protocol applies to postpartum patients with confirmed chronic Q fever whose serologic titers remain elevated beyond 12 months post-delivery. Persistent elevated titers in this setting indicate ongoing infection and signal the need for structured, long-duration management rather than observation alone.
The evidence-based approach for this population involves a specific dual-drug antibiotic combination administered over a prolonged course. The complete regimen — including the agents involved, their dosing schedule, and the full treatment duration — is detailed in the structured protocol below.